Product Information
Methyl 4-(carbamimidamidomethyl)benzoate (MGCD0103) is a molecule that has been shown to induce apoptosis in cancer cells. It is an orally administered histone deacetylase inhibitor that blocks the enzyme from removing acetyl groups from histones and other proteins. MGCD0103 inhibits the expression of genes that contribute to tumorigenesis, such as those for inflammatory cytokines. MGCD0103 is currently undergoing clinical trials for cancer treatment.
Chemical properties
Technical inquiry about: 3D-LEB08030 Methyl 4-(carbamimidamidomethyl)benzoate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.